The TARN Probability of Survival Model
August 2019
Probability of survival
A probability of survival (PS) is calculated for each injured patient and retained on the TARN database. This allows comparative outcome analyses for hospitals and for other groups of patients to be performed.
Early Outcome Prediction Models using TRISS
In 1984 the Probability of Survival (PS) of each patient was originally calculated from the Revised Trauma Score, Injury Severity Score, age and method of injury (blunt or penetrating). This was known as the
TRISS model. There were a number of reasons to develop a European model from this early method:
- The Revised Trauma Score incurred a high number of cases with unrecorded data (respiratory rate, systolic blood pressure and Glasgow Coma Scale).
- The way that the Injury Severity Score was incorporated into the calculation contradicted some statistical reasoning.
- Patients who were transferred to another hospital for further care were excluded.
- Patients who were intubated at scene were excluded.
- Children were included but not in a statistically acceptable fashion
The first TARN PS model
In 2004 a new PS logistic regression model based on age, gender, Injury Severity Score (ISS) and Glasgow Coma Score (GCS) was launched by TARN. Where GCS was missing, intubation was used instead. Each
element in the model carried a weighting derived from retrospective analysis of the TARN database. As the nature of the trauma population changes over time, we recalculated these weightings in 2009 and 2012.
During 2014 we recalculated the coefficients once more and, at the same time updated the model by adding measures to include the comorbidities of patients and a “true 30 day” outcome. This has resulted
in 2 case mix standardised outcome (Ws) charts for your hospital.
The coefficients were recalculated again in 2017, the Ws model uses the PS17 values (recalibrated for Ps19).
Why we added comorbidities
For PS to work effectively we must include all characteristics of the injured patients so that we are comparing like with like. In addition to the patient’s age, gender, injuries and level of consciousness,
we also need to consider the patient’s state of health. A patient with a severe pre-existing medical condition is different to a patient who was in good health at the time of injury. We handled this
comorbidity using a modified version of the Charlson Comorbidity Index, which assigns weightings to certain medical conditions (mCCI). Twenty one groups of comorbidity were created and a weight was allocated
to each of these groups. The weights were derived according to the strength of the relationship between the disease group and outcome.
Earlier this year we circulated an email to all hospital staff that informed you of this development and advised that comorbid data would be essential. Data on pre-existing medical conditions (PMC) has also
been included in the Accreditation information for this reason.
PMC data is essential!
Why we added outcome at 30 days
Outcome (alive or dead) at 30 days from injury has historically been used in the calculation for Ws. However many patients are discharged before this 30 day point. In order to include these patients we need
to know whether patients died at or before the 30 day point after leaving hospital. To do this, we now receive information about post-discharge deaths from the Office of National Statistics (ONS) and use
this information in one of the calculations of Ws for your hospital. In the future you will receive two Ws charts – one using outcome in hospital and one using the “true 30 day” outcome.. The data linkage is
carried out using the patients’ NHS number. We do acknowledge that there are some patients, for example, patients with no fixed abode or who are foreign nationals will not have an NHS number. Excepting this
group of patients
NHS Number is essential!
The case mix standardised outcome measure Ws
Case mix standardisation uses bands of probability of survival. The bands were revised in Ps17 using an increasingly robust methodology so that there are an equal number of deaths in each band. You will see
these in the PS Breakdown table on the TARN website and in your Clinical Reports.
Probability of Survival (Ps19) Model recalibration
The TARN prediction model is calibrated every 2-3 years as a routine exercise.
This is mainly due to the improvement in trauma care and sometimes to a change in the demographics.
The new model, Ps19 is an updated version of Ps17; it uses the same criteria but a change in the age categorisation has been introduced as follows:
< 1yr, 1–10yrs; 11-15yrs; 16–44yrs; 45–54yrs; 55–64yrs; 65–74yrs; 75–84yrs; 85+yrs.
Ps19 has been derived by using information from the TARN database about patients that arrived between April 2017 and March 2019 (inclusive).
Small numbers of patients often affect the accuracy of Ws and therefore the 95% confidence intervals will be large.
Any change in Ws that is encapsulated by these confidence limits means that there is no
statistically significant change.
If the numbers of patients submitted are small then you should review the Case ascertainment figures and if <80% try to improve these.
Since 2014 the Ps model has included comorbidity so you must be sure to complete all of this data. A large number of patients with missing PMC data will affect the Ws score.
Detailed Ps19 Model
The Probability of Survival for each patient is calculated using the information in the table below which shows the logistic regression coefficients for patient characteristics (Ps19).
loge is the natural logarithm.
ISS is transformed using fractional polynomial technique for a better fit of the model.
mCCI represents the categorised modified Charlson Comorbidity Index.
b = is defined as the linear combination of the regression coefficients and the values of the corresponding patient’s characteristics (ISS, GCS, modified CCI, age and gender) and the constant e = 2.718282 (the base of Napierian logarithms).
Outcome at 30 days or discharge
|
Outcome at 30 days via ONS data linkage
|
Predictors
|
Coefficient
|

|
-2.04374
|

|
-1.909581
|
GCS=3
|
-4.49297
|
GCS 4 - 5
|
-3.34416
|
GCS 6 - 8
|
-2.35783
|
GCS 9 - 12
|
-1.60302
|
GCS 13 - 14
|
-0.52474
|
GCS 15 (reference)
|
0.00000
|
GCS "Intubated"
|
-3.685728
|
mCCI Not Known
|
-0.99161
|
mCCI 0 (reference)
|
0.00000
|
mCCI 1 - 5
|
-0.51906
|
mCCI 6 - 10
|
-0.96600
|
mCCI > 10
|
-1.53458
|
Age < 1
|
-0.01109
|
Age 1 - 10
|
+0.17983
|
Age 11 - 15
|
-0.16049
|
Age 16 - 44 (reference)
|
0.00000
|
Age 45 - 54
|
-0.39462
|
Age 55 - 64
|
-0.94640
|
Age 65 - 74
|
-1.73794
|
Age 75 - 85
|
-2.54999
|
Age > 85
|
-3.10822
|
Gender Male (reference)
|
0.00000
|
Gender Female
|
-0.1847913
|
Age &1t; 1 x Female
|
+0.02051
|
Age 1 - 10 x Female
|
-0.26727
|
Age 11 - 15 x Female
|
+0.71834
|
Age 45 - 54 x Female
|
+0.07896
|
Age 55 - 64 x Female
|
+0.12845
|
Age 65 - 74 x Female
|
+0.25509
|
Age 75 - 85 x Female
|
+0.42293
|
Age > 85 x Female
|
+0.49363
|
Constant
|
5.67829
|
|
Predictors
|
Coefficient
|

|
-2.03953
|

|
-1.89033
|
GCS=3
|
-4.36388
|
GCS 4 - 5
|
-3.17872
|
GCS 6 - 8
|
-2.11443
|
GCS 9 - 12
|
-1.53609
|
GCS 13 - 14
|
-0.53992
|
GCS 15 (reference)
|
0.00000
|
GCS "Intubated"
|
-3.52241
|
mCCI Not Known
|
-0.79432
|
mCCI 0 (reference)
|
0.00000
|
mCCI 1 - 5
|
-0.62056
|
mCCI 6 - 10
|
-1.07724
|
mCCI > 10
|
-1.74943
|
Age 0 - 5
|
0.06055
|
Age 6 - 10
|
0.47385
|
Age 11 - 15
|
-0.08743
|
Age 16 - 44 (reference)
|
0.00000
|
Age 45 - 54
|
-0.33766
|
Age 55 - 64
|
-0.90488
|
Age 65 - 74
|
-1.70869
|
Age > 75
|
-2.85978
|
Gender Male (reference)
|
0.00000
|
Gender Female
|
-0.18650
|
Age 0 - 5 x Female
|
-0.24235
|
Age 6 - 10 x Female
|
0.02104
|
Age 11 - 15 x Female
|
0.59432
|
Age 45 - 54 x Female
|
-0.10280
|
Age 55 - 64 x Female
|
0.22073
|
Age 65 - 74 x Female
|
0.25692
|
Age > 75 x Female
|
0.43942
|
Constant
|
5.49085
|
|